Tailored ad-hoc projects for pharma, biotech and food industry based on decades of expertise in the microbiome field.
Composition and functionality of the microbiome using next generation sequencing technologies (NGS) coupled with bioinformatics.
Next generation biotherapeutics development and novel probiotics thanks to our proprietary bacterial library.
storage of your microbiota as a backup enabling therapeutic applications under strict privacy and quality control.
GutAlive® – Anaerobic microbiome collection kit
MICROBIOTA IDENTITY
GutAlive® is design to generate an anaerobic atmosphere enabling oxygen sensitive bacteria to survive (increase viability) maintaining the microbiota original identity.
MICROBIOTA DIVERSITY
Strict anaerobe microbes survive using GutAlive®, ensuring higher bacterial species diversity without disrupting the original microbiota composition and their relative abundance.
SAMPLE STABILITY OVER 72 HOURS
GutAlive® warranties the microbiota stability over 72 hours to ensure the proper conditions for sample collection and transport to the laboratory.
PROTOCOL NORMALIZATION
Protocol normalization and standardization is key to avoid variations within analyses and downstream applications of the sample, especially on the therapeutics.
BACTERIAL VIABILITY
GutAlive® maintains the bacterial viability together with DNA stability and integrity, a best in class device suitable for both anaerobic bacteria isolation and microbiome analyses.
DNA STABILITY
GutAlive® is a suitable device for microbiome sampling with no limitation on DNA quality and quantity for NGS technologies and microbiome analyses through 16s rRNA sequencing or metagenomics.
ISOLATION OF DIVERSE BACTERIAL GENERA
The use of GutAlive® to collect and transport the stool sample at room temperatura enables downstream isolation of a wide diversity of bacterial genera, including anaerobic bacteria.
NEWS
You can follow the latest news of MicroViable in this section
Microviable Therapeutics welcomes Marta Fernández on board.
Marta has a degree in Biology (2014) and a Food [...]
Borja Sánchez, co-founder of Microviable Therapeutics, among the 62 most influential scientists.
Asturias has 62 scientists among the most influential in the [...]
Microviable will be attending Bio-Europe 2022
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, [...]